4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001753159-26-000014
Co-Chief Executive Officer sold 260,000 shares at an average $151.20 ($39,312,654)
- Co-Chief Executive Officer acquired 254,832 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Talasaz AmirAli · Co-Chief Executive Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +111,804 | $4.18 | $467,341 | 1,998,308 | I |
| 2026-06-26 | Sale : show line 2 in the form 10b5-1 | −64,037 | $150.49 | $9,636,838 | 1,934,271 | I |
| 2026-06-26 | Sale : show line 3 in the form 10b5-1 | −52,935 | $151.16 | $8,001,628 | 1,881,336 | I |
| 2026-06-29 | Exercise or conversion : show line 4 in the form 10b5-1 | +143,028 | $4.18 | $597,857 | 2,024,364 | I |
| 2026-06-29 | Sale : show line 5 in the form 10b5-1 | −25,812 | $150.53 | $3,885,434 | 1,998,552 | I |
| 2026-06-29 | Sale : show line 6 in the form 10b5-1 | −70,513 | $151.47 | $10,680,315 | 1,928,039 | I |
| 2026-06-29 | Sale : show line 7 in the form 10b5-1 | −46,663 | $152.20 | $7,102,319 | 1,881,376 | I |
| 2026-06-29 | Sale : show line 8 in the form 10b5-1 | −40 | $153.00 | $6,120 | 1,881,336 | I |
| Open-market sales · 260,000 sh · avg $151.20 · $39,312,654 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-26 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | −111,804 | 172,025 | D |
| 2026-06-29 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) | −143,028 | 28,997 | D |
Loading xslF345X06/wk-form4_1782854022.xml…